FINWIRES · TerminalLIVE
FINWIRES

Wedbush Downgrades Passage Bio to Neutral From Outperform, Cuts Price Target to $8 From $32

-- Passage Bio (PASG) has an average rating of overweight and mean price target of $12, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles